Related Experiment Videos
Insights
Depression is common in both hypertensive and non-hypertensive patients. However, hypertensive individuals with a history of psychiatric conditions, particularly those treated with methyl dopa, showed higher depression rates.
Area of Science:
- Clinical Psychology
- Cardiology
- Psychiatry
Background:
- Depression is a significant comorbidity affecting patient health outcomes.
- Understanding depression prevalence in chronic illness, including hypertension, is crucial for integrated care.
Purpose of the Study:
- To investigate the prevalence of depression in hypertensive and non-hypertensive chronically ill outpatients.
- To identify factors associated with higher depression rates in these patient groups.
Main Methods:
- A prospective study involving 89 hypertensive and 46 non-hypertensive outpatients.
- Mood rating scales were administered at regular intervals over a one-year period.
- Analysis included comparison of depression prevalence between groups and subgroups.
Main Results:
- A high prevalence of depression was observed in both hypertensive and non-hypertensive patient groups.
- No significant difference in overall depression prevalence was found between hypertensive and non-hypertensive patients.
- Hypertensive patients with prior psychiatric histories exhibited a higher prevalence of depression.
- This elevated rate in hypertensive patients with psychiatric histories was largely attributable to those treated with methyl dopa.
Conclusions:
- Depression is highly prevalent in chronically ill outpatients, irrespective of hypertension status.
- Hypertension management, particularly methyl dopa use in patients with psychiatric histories, warrants attention for potential depression risks.
- Further research is needed to explore the relationship between antihypertensive medications and mood disorders.
Abstract:
Eighty-nine new referral hypertensive out-patients and 46 new referral non-hypertensive chronically physically ill out-patients completed a mood rating scale at regular intervals for one year. The results showed a high prevalence of depression in both groups of patients, with no preponderance in the hypertensive group. Hypertensive patients with psychiatric histories had a higher prevalence of depression than the comparison patients. This was accounted for by a significant number of depressions occurring in methyl dopa treated patients with psychiatric histories.